Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | University of California San Diego UCSD | 193 |
| 2 | Kyowa Kirin Co Ltd | 107 |
| 3 | Pioneer Hi-Bred International Inc | 98 |
| 4 | Philip Morris Products SA | 83 |
| 5 | University of California | 80 |
| 6 | BASF SE | 65 |
| 7 | University of California Berkeley | 64 |
| 8 | Arcadia Biosciences Inc | 63 |
| 9 | Bayer CropScience NV | 60 |
| 10 | BASF Plant Science GmbH | 58 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 2,956 |
| 2 | C07K | Peptides | 1,731 |
| 3 | A61K | Medicinal preparations | 1,202 |
| 4 | A61P | Therapeutic activity (drug indications) | 1,161 |
| 5 | C12Q | Measuring/testing involving enzymes | 1,020 |
| 6 | A01H | 1,013 | |
| 7 | G01N | Investigating / analysing materials | 584 |
| 8 | Y02A | Climate change adaptation | 574 |
| 9 | C12Y | Enzyme nomenclature (EC numbers) | 521 |
| 10 | A01K | 390 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| ENU (ethylnitrosourea) mutation technology based mouse model of human CHARGE syndrome | 2013 | NANJING UNIVERSITY | 2 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Carcinogens and Genotoxicity Assessment | 9 |
| 2 | Glioma Diagnosis and Treatment | 6 |
| 3 | CRISPR and Genetic Engineering | 4 |
| 4 | Epigenetics and DNA Methylation | 4 |
| 5 | Zebrafish Biomedical Research Applications | 4 |
| 6 | Cancer Cells and Metastasis | 2 |
| 7 | Cancer, Hypoxia, and Metabolism | 2 |
| 8 | Connexins and lens biology | 2 |
| 9 | DNA Repair Mechanisms | 2 |
| 10 | Immune Response and Inflammation | 2 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Martin Hrabě de Angelis | Institute of Groundwater Ecology | 39 |
| 2 | Bruce Beutler | Scripps Research Institute | 31 |
| 3 | Manfred F. Rajewsky | West German Heart and Vascular Center Essen | 31 |
| 4 | Monica J. Justice | Baylor College of Medicine | 27 |
| 5 | Steve D. M. Brown | Mary Lyon Centre at MRC Harwell | 16 |
| 6 | Robert H. Heflich | National Center for Toxicological Research | 15 |
| 7 | A. Koestner | The Ohio State University | 14 |
| 8 | Helmut Fuchs | Institute of Groundwater Ecology | 12 |
| 9 | A. Neuhäuser-Klaus | Institute of Groundwater Ecology | 11 |
| 10 | A.D. Tates | Leiden University | 11 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Mutagenesis and Mapping of a Mouse Gene, Clock , Essential for Circadian Behavior | 1994 | 1620 | Circadian rhythm and melatonin |
| A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse | 1990 | 1593 | Cancer Cells and Metastasis |
| Hedgehog signalling in the mouse requires intraflagellar transport proteins | 2003 | 1440 | Epigenetics and DNA Methylation |
| Identification of Lps2 as a key transducer of MyD88-independent TIR signalling | 2003 | 1230 | Immune Response and Inflammation |
| Programmed Anuclear Cell Death Delimits Platelet Life Span | 2007 | 1027 | Cell death mechanisms and regulation |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of NE-Urea?
How extensive is the research and patent coverage for this compound?
Which organizations hold the most patents related to NE-Urea?
What are the primary research topics associated with NE-Urea in the scientific literature?
What was the trend in patent and publication activity for NE-Urea between 2016 and 2024?